M&A Deal Summary

Piramal Enterprises Acquires Hemmo Pharmaceutical

On March 31, 2021, Piramal Enterprises acquired medical products company Hemmo Pharmaceutical

Acquisition Highlights
  • This is Piramal Enterprises’ 2nd transaction in the Medical Products sector.
  • This is Piramal Enterprises’ 5th transaction in India.

M&A Deal Summary

Date 2021-03-31
Target Hemmo Pharmaceutical
Sector Medical Products
Buyer(s) Piramal Enterprises
Deal Type Add-on Acquisition
Advisor(s) Torreya Partners (Financial)

Target

Hemmo Pharmaceutical

Mumbai, India
Hemmo Pharmaceutical develops and manufactures peptide APIs. Its portfolio covers 30+ APIs including generic peptides, peptide NCEs and peptides in clinical development which it offers to pharma and research companies in both domestic and global markets. Hemmo Pharmaceutical was founded in 1979 and is based in Mumbai, India.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Piramal Enterprises

Mumbai, India

Category Company
Founded 1947
Sector Healthcare Services
Employees16,035
Revenue 89.2B INR (2025)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, Maharashtra.


DEAL STATS #
Overall 12 of 12
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 6 of 6
Country: India M&A 5 of 5
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-17 Decision Resources Group

Burlington, Massachusetts, United States

Decision Resources Group (DRG) is a premier provider of high-value data, analytics and insights products, and services to the healthcare industry. DRG helps clients propel commercial success with evidence-based business decisions by delivering expert consultation, data, and analysis enhanced by machine learning artificial intelligence (AI). With collaborative experts spanning healthcare markets, disease areas, and data science disciplines, DRG clients have unprecedented access to the expertise, data, and AI-technology solutions they require to anticipate customer needs and generate new solutions to healthcare challenges.

Sell $950M